pancreatic cancer cells

Researchers Identify Familial Pancreatic Cancer Gene

Researchers at Harvard Medical School have sequenced the genomes of a family in which multiple members had pancreatic cancer and found a mutation in a gene linked to the RAS signaling pathway that controls cell growth and death. Researchers argue that the into how RABL3 impacts the signaling pathway could lead to novel targeted therapy.

Thrive Raises $257M in Series B to Advance CancerSEEK Liquid Biopsy

Thrive said its goal is to incorporate CancerSEEK into routine medical care, where it can detect more cancers at earlier stages.
At Home Coronavirus Test

Five COVID-19 Test Developers to Watch

The coronavirus pandemic compels diagnostics companies to bring new assays, technologies to market.

ACMG Launches Evidence-Based Guidelines for Genetic, Genomic Testing

The American College of Medical Genetics and Genomics (ACMG) said today it will establish a program designed to develop new evidence-based guidelines in medical...
Innovative Genomics Institute’s “pop-up” SARS-CoV-2 testing laboratory

Building a COVID-19 Pop-Up Testing Lab

Postdocs working in the lab of Jennifer Doudna at UC Berkeley bring the testing lab online in just three weeks.

New Antibody Test for COVID-19 Targets Unique Region of Spike Protein

The antibody test is based on the receptor-binding domain (RBD) of the spike protein. The RBD-based antibody test measures the levels of that domain, which the authors found correlate to the levels of neutralizing antibodies.
Freenome’s artificial intelligence (AI) genomics platform

AI Predicts Patient Phenotypes that Will Develop Drug Resistance

Findings from the new study could point to methods for identifying diseases and predicting their behaviors that are faster, simpler, less expensive, and more accurate than current standard techniques.
DNA, doctor using tablet

Keeping up with the Genomes

Molecular diagnostics providers seek ways to maintain services in a world consumed by COVID-19.

GeneDx to Develop Clinical Assays Based on Bionano’s Saphyr System

GeneDx will develop assays targeting muscular dystrophies, developmental, and reproductive disorders using Saphyr, which detects CNVs, FSHD repeat contractions, repeat expansions, balanced and unbalanced translocations, and other complex rearrangements.
Extending a collaboration launched last year

Celsee, IncellDx Sign Lung Cancer CTC PD-L1 Agreement

The companies will co-commercialize their respective single-cell technologies for CTCs and PD-L1 expression following positive study results
Scroll Up